000 01758 a2200481 4500
005 20250513104600.0
264 0 _c19961025
008 199610s 0 0 eng d
022 _a0360-3997
024 7 _a10.1007/BF01487745
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHilger, R A
245 0 0 _aInhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.
_h[electronic resource]
260 _bInflammation
_cFeb 1996
300 _a57-70 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAluminum
_xpharmacology
650 0 4 _aBasophils
_xdrug effects
650 0 4 _aCalcimycin
_xpharmacology
650 0 4 _aCalcium
_xmetabolism
650 0 4 _aDepression, Chemical
650 0 4 _aGTP-Binding Proteins
_xmetabolism
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHumans
650 0 4 _aInterleukin-8
_xbiosynthesis
650 0 4 _aIonophores
_xpharmacology
650 0 4 _aLeukocytes, Mononuclear
_xdrug effects
650 0 4 _aLeukotriene B4
_xbiosynthesis
650 0 4 _aN-Formylmethionine Leucyl-Phenylalanine
_xpharmacology
650 0 4 _aNeutrophils
_xdrug effects
650 0 4 _aPlatelet Activating Factor
_xphysiology
650 0 4 _aPlatelet Membrane Glycoproteins
_xantagonists & inhibitors
650 0 4 _aReceptors, Cell Surface
650 0 4 _aReceptors, G-Protein-Coupled
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aSodium Fluoride
_xpharmacology
650 0 4 _aThiazoles
_xpharmacology
650 0 4 _aThiazolidines
700 1 _aKöller, M
700 1 _aKönig, W
773 0 _tInflammation
_gvol. 20
_gno. 1
_gp. 57-70
856 4 0 _uhttps://doi.org/10.1007/BF01487745
_zAvailable from publisher's website
999 _c8918476
_d8918476